Amylyx Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2025 | 8.80 M | $56.41 M | 54.45% | 9.87% |
| PERCEPTIVE ADVISORS LLC | 08/14/2025 | 7.90 M | $50.65 M | 0.36% | 8.87% |
| TCG CROSSOVER MANAGEMENT, LLC | 08/14/2025 | 5.94 M | $38.10 M | 0.00% | 6.67% |
| BLACKROCK, INC. | 08/12/2025 | 5.51 M | $35.32 M | 130.80% | 6.18% |
| POINT72 ASSET MANAGEMENT, L.P. | 08/14/2025 | 4.54 M | $29.08 M | 394.70% | 5.09% |
| VANGUARD GROUP INC | 08/11/2025 | 4.50 M | $28.83 M | 9.27% | 5.05% |
| SATURN V CAPITAL MANAGEMENT LLC | 08/13/2025 | 3.26 M | $20.90 M | 34.38% | 3.66% |
| FMR LLC | 08/14/2025 | 3.05 M | $19.54 M | 163.22% | 3.42% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 08/14/2025 | 2.93 M | $18.81 M | 0.00% | 3.29% |
| 683 CAPITAL MANAGEMENT, LLC | 08/14/2025 | 2.16 M | $13.85 M | -10.43% | 2.42% |
| ALMITAS CAPITAL LLC | 08/14/2025 | 2.12 M | $13.61 M | 0.00% | 2.38% |
| GREAT POINT PARTNERS LLC | 08/14/2025 | 2.00 M | $12.82 M | 10.38% | 2.24% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/08/2025 | 1.69 M | $10.85 M | 109.93% | 1.90% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2025 | 1.51 M | $9.69 M | -50.94% | 1.70% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 08/14/2025 | 1.26 M | $8.11 M | 100.00% | 1.42% |
| UBS GROUP AG | 08/14/2025 | 1.25 M | $8.03 M | -9.73% | 1.41% |
| BOXER CAPITAL MANAGEMENT, LLC | 08/14/2025 | 1.23 M | $7.85 M | -30.00% | 1.37% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2025 | 1.21 M | $7.72 M | -18.11% | 1.35% |
| WOODLINE PARTNERS LP | 08/14/2025 | 1.20 M | $7.69 M | -25.42% | 1.35% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 08/07/2025 | 1.15 M | $7.40 M | -3.77% | 1.30% |
| STATE STREET CORP | 08/14/2025 | 1.01 M | $6.47 M | 285.40% | 1.13% |
| NORTHERN TRUST CORP | 08/13/2025 | 820.16 K | $5.26 M | 488.64% | 0.92% |
| ABRDN PLC | 07/24/2025 | 738.66 K | $4.73 M | -69.61% | 0.83% |
| PFM HEALTH SCIENCES, LP | 08/14/2025 | 732.26 K | $4.69 M | -12.21% | 0.82% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2025 | 650.00 K | $4.17 M | 100.00% | 0.73% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2025 | 646.44 K | $4.14 M | 451.86% | 0.73% |
| DEUTSCHE BANK AG\ | 08/12/2025 | 616.92 K | $3.95 M | 8.07% | 0.69% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2025 | 588.41 K | $3.77 M | 57.81% | 0.66% |
| INVESCO LTD. | 08/13/2025 | 586.88 K | $3.76 M | 1,184.38% | 0.66% |
| ACADIAN ASSET MANAGEMENT LLC | 08/07/2025 | 569.08 K | $3.65 M | 135.05% | 0.64% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2025 | 558.85 K | $3.58 M | -26.67% | 0.63% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2025 | 499.76 K | $3.20 M | 45.61% | 0.56% |
| TWO SIGMA ADVISERS, LP | 08/14/2025 | 470.00 K | $3.01 M | -27.67% | 0.53% |
| BANK OF AMERICA CORP /DE/ | 08/14/2025 | 451.81 K | $2.90 M | -43.12% | 0.51% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2025 | 438.03 K | $2.81 M | -53.54% | 0.49% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2025 | 396.20 K | $2.54 M | -23.08% | 0.44% |
| DIMENSIONAL FUND ADVISORS LP | 08/12/2025 | 373.74 K | $2.40 M | 202.44% | 0.42% |
| ORBIMED ADVISORS LLC | 08/14/2025 | 313.20 K | $2.01 M | -10.00% | 0.35% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2025 | 288.62 K | $1.85 M | -0.71% | 0.32% |
| ALPHA WAVE GLOBAL, LP | 08/13/2025 | 275.84 K | $1.77 M | 47.26% | 0.31% |
| J. GOLDMAN & CO LP | 08/14/2025 | 258.60 K | $1.66 M | 100.00% | 0.29% |
| Y-INTERCEPT (HONG KONG) LTD | 08/01/2025 | 240.38 K | $1.54 M | 100.00% | 0.27% |
| TFG ASSET MANAGEMENT GP LTD | 08/14/2025 | 218.75 K | $1.40 M | 100.00% | 0.25% |
| ALDEBARAN CAPITAL, LLC | 08/12/2025 | 217.83 K | $1.40 M | -15.98% | 0.24% |
| FEDERATED HERMES, INC. | 08/13/2025 | 203.93 K | $1.31 M | 0.56% | 0.23% |
| JANE STREET GROUP, LLC | 08/14/2025 | 186.99 K | $1.20 M | -43.54% | 0.21% |
| GSA CAPITAL PARTNERS LLP | 07/22/2025 | 170.53 K | $1.09 M | 638.72% | 0.19% |
| NUVEEN, LLC | 08/12/2025 | 155.54 K | $996.99 K | 100.00% | 0.17% |
| BANK OF NEW YORK MELLON CORP | 08/05/2025 | 150.84 K | $966.86 K | 100.00% | 0.17% |
| BANK OF MONTREAL /CAN/ | 08/05/2025 | 143.51 K | $919.91 K | 0.00% | 0.16% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Amylyx Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 180 institutional investors and hedge funds held shares of Amylyx Pharmaceuticals, Inc.. The most heavily invested institutionals were:
VOYA INVESTMENT MANAGEMENT LLC: 12,990
CWM, LLC: 1,186
Global Retirement Partners, LLC: 1,000
North Capital, Inc.: 501
GAMMA Investing LLC: 125
Rise Advisors, LLC: 64
88.04% of Amylyx Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 82.52 M shares in the last 24 months. This purchase volume represents approximately $1.23 B in transactions.